Labor Induction with Intravaginal Misoprostol versus Spontaneous Labor: Maternal and Neonatal Outcomes.

Esra Ozbasli Muhterem Melis Canturk Elif Ganime Aygün Selin Ozaltin Mete Gungor

Published in: BioMed research international (2022)

Intravaginal misoprostol seems to be a promising medical agent for labor induction due to its high delivery rates within 12 hours and the absence of negative fetal outcomes, its ease of storage, and affordable cost.

Keyphrases

healthcare
type diabetes
metabolic syndrome
adipose tissue
physical activity
skeletal muscle
glycemic control
insulin resistance
weight gain